Information Provided By:
Fly News Breaks for November 4, 2016
ICPT
Nov 4, 2016 | 10:23 EDT
Leerink analyst Joseph Schwartz lowered his price target for Intercept to $116 from $159 due to tempered expectations for Phase 3 trial enrollment timing and ultimate NASH market entry. The analyst reiterates a Market Perform rating on the shares.
News For ICPT From the Last 2 Days
There are no results for your query ICPT